Inactive Instrument

Press Releases La Jolla Pharmaceutical Company OTC Bulletin Board

Equities

US5034596040

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2022	La Jolla Pharmaceutical Announces Management Changes	CI
2022	La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K	22-08-22	PU
LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-08-22	AQ
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-15	AQ
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC	22-07-11	BU
Twitter, Las Vegas Sands fall; Mullen, La Jolla rise	22-07-11	AQ
La Jolla Pharmaceutical : Innoviva to Acquire La Jolla Pharmaceutical Company - Form 8-K	22-07-11	PU
LA JOLLA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-07-11	AQ
Innoviva to Acquire La Jolla Pharmaceutical Company	22-07-11	BU
La Jolla Pharmaceutical: Q1 Earnings Snapshot	22-05-16	AQ
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-16	AQ
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress	22-05-16	BU
La Jolla Pharmaceutical : Corporate Presentation March 2022	22-03-16	PU
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Corporate Progress	22-03-09	BU
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	22-03-09	AQ
LA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (form 8-K)	22-02-16	AQ
La Jolla Pharmaceutical : Announces Share Repurchase Plan - Form 8-K	21-11-18	PU
LA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (form 8-K)	21-11-18	AQ
La Jolla Pharmaceutical Company Announces Share Repurchase Plan	21-11-17	BU
La Jolla Corporate Presentation November 2021	21-11-05	PU
La Jolla Pharmaceutical: Q3 Earnings Snapshot	21-11-04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases La Jolla Pharmaceutical Company OTC Bulletin Board

Equities

US5034596040

Press Releases

Filters